BARCLAYS PLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,752
+2.9%
197,647
+36.7%
0.00%0.0%
Q2 2023$4,617
+30.4%
144,532
+25.0%
0.00%
+50.0%
Q1 2023$3,542
-25.5%
115,629
-4.9%
0.00%0.0%
Q4 2022$4,757
-99.9%
121,619
+11.8%
0.00%
-66.7%
Q3 2022$5,179,000
+339.3%
108,736
+256.9%
0.01%
+500.0%
Q2 2022$1,179,000
+37.3%
30,469
+102.8%
0.00%0.0%
Q1 2022$859,00015,0250.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders